ReviewCurrent hematologic malignancy reports2021

Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials.

Brady L SteinPubMed ↗Publisher ↗

No numbers read from the abstract.